Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using our IMPACT™ platform, we are addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements of biologics drug discovery – structural biology, protein engineering and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases. The company is backed by a strong syndicate of life sciences investors and is located in the Boston biotechnology hub.

Biotechnology

Education

Seismic Therapeutic

Jo Viney

Melanie Manning

Yi Xing

Ivan Mascanfroni

Daniela Cipolletta

Jyothsna Visweswaraiah

John Sundy

Kevin Otipoby

Edward Freedman

Maude Tessier

Debora Marks

Nathan Higginson-Scott

The Leadership Team at Seismic Therapeutic is responsible for guiding the company's strategic direction and overseeing the integration of machine learning in the biologics discovery process. Composed of industry pioneers and experts in immunology, the team drives innovation, aligns research and development efforts, and fosters collaboration with investors and academic institutions to accelerate the development of novel therapies for autoimmune diseases. Their combined expertise ensures that Seismic Therapeutic remains at the forefront of biotechnology advancements, delivering optimized, patient-focused solutions.

Leadership Team

Scientific Research and Development Team

Directors and Managers

Leadership Team

About

Team members

Other teams at Seismic Therapeutic

Scientific Research and Development Team

Directors and Managers